Gene · 10672
GNA13: G protein subunit alpha 13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GNA13: G protein subunit alpha 13. Genes, record 10672. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10672
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q14344 | Guanine nucleotide-binding protein subunit alpha-13 | 377 | 17 | Ensembl, GeneID, HGNC |
Source UniProt
Patents40
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026053553 A | 2026-03-25 | 156 | Q14344 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 48439 | Q14344 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 13053 | Q14344 | Espacenet |
| WO 2025224050 A1 | 2025-10-30 | 1 | Q14344 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 14694 | Q14344 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 14694 | Q14344 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 13053 | Q14344 | Espacenet |
| US 12269900 B2 | 2025-04-08 | 1 | Q14344 | Espacenet |
| US 12269900 B2 | 2025-04-08 | 10 | Q14344 | Espacenet |
| EP 4516806 A2 | 2025-03-05 | 156 | Q14344 | Espacenet |
1 to 10 of 40
See all 40 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,466
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GNA13 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 10 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| ZIASC000550 | Lymphoma Disease Discovery and Definition | 7 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 6 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 5 | 2025 |
| R01MH054137 | Structure and Function of Dopamine Receptors | 5 | 2025 |
| R01AI040098 | B lymphocyte Migration and Homeostasis | 4 | 2025 |
| R01DA036596 | Regulation of Neuronal GPCR Signaling | 4 | 2025 |
| R35HL150797 | Mechanisms of integrin signaling and a new anti-platelet/anti-inflammatory approach | 4 | 2025 |
| T32HL007829 | Training Program in Lung Biology and Pathobiology | 4 | 2025 |
1 to 10 of 1,466Source NIH's project files
See all 1,466 nih grantsPapers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heterotrimeric G proteins containing Gβ1γ2 subunits exhibit subtype-specific mobility differences in live cells. | PLoS One | 2026 | 42809568 | PubTator, text mining | PubMed |
| [A retrospective analysis of clinicopathological features and efficacy in 51 patients with high-grade B-cell lymphoma with 11q abnormalities]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | 42706163 | PubTator, text mining | PubMed |
| In vivo genome-wide CRISPR screens of human T cells in solid tumours. | Nature | 2026 | 42587162 | PubTator, text mining | PubMed |
| [Analysis of the Gene Mutation Distribution and Its Relationship with Prognosis in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma by Next Generation Sequencing]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42544655 | PubTator, text mining | PubMed |
| Gα13 signaling in the nervous system: Roles in neurodevelopment, stress responses, and neurological disorders. | Cell Signal | 2026 | 42503407 | PubTator, text mining | PubMed |
| GPR56 regulates the expression of key androgen-target genes via G13-Rho-PKN1 axis and is overexpressed in prostate cancer. | J Steroid Biochem Mol Biol | 2026 | 42498205 | PubTator, text mining | PubMed |
| Polyclonal evolution of lymphoproliferative disorders in XLP1. | J Hum Immun | 2026 | 42169999 | PubTator, text mining | PubMed |
| IGF1 Binding to Integrin αvβ3 Induces Direct Gα13 Binding to IGF1R Kinase. | Int J Mol Sci | 2026 | 42123623 | PubTator, text mining | PubMed |
| Rare variant in intracellular loop-2 alters the spatial distribution and transducer coupling selectivity of the ghrelin receptor. | Mol Pharmacol | 2026 | 41980512 | PubTator, text mining | PubMed |
| The atypical adhesion GPCR ADGRA1 controls hippocampal inhibitory circuit function. | Cell Rep | 2026 | 41961591 | PubTator, text mining | PubMed |
1 to 10 of 1,983
See all 1,983 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10672
GET https://conductscience.org/api/genes/v1/10672/patents?page=2